TREAT Asia News
TREAT Asia News
-
Cannabis, Youth, and Public Health: Assessing the Pitfalls of Legalization
Decriminalization of cannabis in Thailand deserves public health policy guidance to protect youth.
-
HIV and Youth in Thailand: Addressing Suicide Risk
A new study seeks to create mental health interventions for a vulnerable population.
-
HIV Care Continuum & Beyond: A New Era for Asia
With TREAT Asia as one of its partners, an initiative strives to strengthen HIV policies and programs across a regional cascade of care.
-
TREAT Asia Calls for Expanded Access to Pediatric Dolutegravir
Facilitating access to formulations of the HIV medicine dolutegravir (DTG) that can be used by infants and children living with HIV in the Asia-Pacific is an urgent concern. In light of recent U.S. and European regulatory approvals of a dispersible version of pediatric DTG, amfAR’s TREAT Asia program recommends steps that national HIV programs and…
-
Recent ARV Stockouts in India Created a Health Crisis for People Living with HIV
An antiretroviral therapy stockout in India limited treatment options and created barriers to healthcare access for people living with HIV.
-
UNAIDS: Most New HIV Infections Among Children Are Preventable
UNAIDS estimates that most of the 150,000 new HIV infections among children in 2020 could have been prevented.
-
COVID-19 Pandemic Threatens HIV Drug Supplies
There is mounting concern in many countries, and emerging acutely in Asia, about a growing shortage of lifesaving antiretroviral drugs as a result of supply chain disruptions and stock-outs caused by the COVID-19 pandemic. Experts fear that further disruptions could halt and even reverse the hard-won progress on HIV/AIDS that has been achieved in many…
-
amfAR’s TREAT Asia program contributes to success of multi-year collaboration on treatment access
More than 58 million people worldwide are living with chronic hepatitis C virus (HCV) infection, according to the World Health Organization. In 2019, an estimated 290,000 people died from diseases such as cirrhosis or liver cancer as a consequence of HCV.
-
TREAT Asia Mourns the Passing of Cambodian Network Investigator Dr. Ly Penh Sun
With the passing of Dr. Ly Penh Sun on November 9, 2021, we lost a regional champion for HIV prevention, care, and research.
-
New Pediatric HIV Site in Indonesia Joins TREAT Asia Research Network
TREAT Asia has added a new site to their pediatric HIV research program with the Kirby Institute, as part of the US NIH-funded International Epidemiology Databases to Evaluate AIDS (IeDEA) Asia-Pacific network.
-
NIH Award Reaffirms TREAT Asia’s Collaborative Leadership on HIV/AIDS in the Asia-Pacific
For 20 years, amfAR’s TREAT Asia program has been working with partners across the region to expand access to treatment for HIV and related conditions such as hepatitis C and improve standards of care.
-
A Forgotten Epidemic: Expanding Treatment Access for Hepatitis C
Despite the existence of direct-acting antivirals (DAAs) that can cure more than 95% of people with HCV, these drugs remain difficult to access for those who need them.
-
ViiV Healthcare and TREAT Asia Partner on Important New Study of Young Adults with HIV
There are more than five million adolescents and young adults living with HIV worldwide, many of whom acquired the virus as infants and must navigate the complex transition from pediatric to adult care. The study of pediatric and adolescent HIV has long been a focus of amfAR’s TREAT Asia program, whose pediatric HIV database, launched…
-
From the Front Lines: Malaysia
At the end of December 2019, the world heard about the cases in China, and everyone hoped that it would go no further. Malaysia saw its first case on January 25th, 2020. We went from having 4 beds for COVID-19 patients at the end of February, to 80 beds for patients in 3 weeks.
-
From the Front Lines: The Philippines
Our institution acts as the referral laboratory for the whole country for the SARS CoV-2 PCR test. But when it comes to patient management, we have a very limited number of beds in our ER and in our ward.